New Delhi: The booster dose will be ideal at six months after receiving the second dose of anti-covid vaccines, Bharat Biotech Cmd Krishna Ella, adding a final decision depending on the government.
Ella’s statement at the present Summit 2021 on Rednesay will further turn on the discussion about this issue, so far, the government and some experts have the view that the booster dose is not urgent and ensures full vaccination with two doses remains a priority.
However, several countries have initiated a booster dose for their elderly population.
In delay by the World Health Organization (WHO) in providing emergency use approval for Covaxin, Ella blamed the “negative campaign” against the vaccine in India.
Hinning politics as a factor that might be behind negative reports, Ella remembers how fast after Prime Minister Narendra Modi took Covaxin’s shot to express confidence in Indian science, innovation and ability ‘atma-nirbhar’, was labeled by BJP vaccine ‘or’ Modi vaccine ‘.
In a question and answer session, Ella indicated that the Covid nasal vaccine developed by Bharat Biotech can be taken instead of the second dose of Covaxin or to protect the previously infected person.
Hope spelling for a mask free future, he said that the nasal vaccine is more effective in preventing viral transmission compared to injection vaccines that do not reach the upper lungs and can eliminate the need for vaccinated individuals to continue to wear masks.
He showed that the phase 2 trial of the nose vaccine was over and the data was being analyzed.
“We must expect (findings) in 3-4 months,” he said, adding that Bharat Biotech also talked to the government about using the Cowin platform to conduct clinical trials.
Guaranteed on the long supervision drawn by WHO in Covaxin, Ella said, “negative things (say about covaxin) in this country put who in a awkward position”.
He said who wants to make sure it does the right or wrong data and is very more intensely reviewed, with every small problem being the main one.
“I think maybe we are the only vaccine in who has gone through so many supervision …
we have gone through more supervision because our internal system too,” CMD said.
Ella Rued how the campaign in Covaxin – as part of that even suicide in Bhopal is projected as a vaccine induced death and scientific journal is asked to investigate – based on projections, interpretations, and ideas delay publications and who pre-qualifying processes.
He said that instead of criticizing the vaccine, people could approach Bharat Biotech for the truth.
“But (people) make your own opinion …
it not only hurts us, but also the future of startup in this country.
If someone wants to oppose the country’s political system, they can take different angles but not in health care.
We are neutral, We want India to succeed.
We want people to benefit, “said scientists.
Who hiding the agreement for the use of Covaxin Emergency in pregnant women, Ella said that even though more than one million pregnant women had been given a safe vaccine in India, which actually saw data in clinical mode.
“We are in work.
We will finish it in the next 2-3 months,” Ella said.
When carrying a vaccine for children, Ella said Bharat Biotech was the only company in the world who conducted clinical trials among those aged between 2 and 18 years.
“Security and immunogenicity are established in this population now.
We have sent data to data controllers but who, unless the national regulator authority agrees, will not approve,” he said.
Installing the supply problem as one of the main obstacles behind the lack of government decisions about approval, Ella said, “Maybe, the government thinks that if it is approved, every child must be vaccinated in the country.
Is there enough supplies …
but for us it is a competition Global …
so I think the Indian government must recognize.
We need rapid indications from India so that we can move who.
“Stop talking about shortcuts in the granting of an emergency nod to Covaxin, Ella clarifies that even though the approval process is accelerated, there is no Indian legal provision Or the rules of ‘Y schedule’ are violated.
“If someone is violated, I will go to jail now,” he said.
Brih Biotech Boss said that unlike other companies such as Pfizer and Oxford, which did not become a R & D and licensed vaccine, Bharat Biotech developed a vaccine from the start.
“I wish I was in the US and did all these things, I would be better known,” he said with a smile.
Booster Dosage After 6 Months Covaxin 2 Shots Ideal: Ella
